MedTrace Logo

Conventional and Molecular Diagnostic Method for Patients With Suspected UTI

NCT02623179 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-10-05

No results posted yet for this study

Summary

In this protocol, the investigators are examining the use of a novel pathogen testing technology and method of identification of antibiotic susceptibility against the conventional C \& S testing for patients with both complicated and uncomplicated UTIs. The investigators will examine the two modes in terms of objective patient related outcomes, i.e. 1) diagnostic accuracy and degree of detail of final analysis; 2) time to resolution of symptoms; 3) quality of life as defined by particularly symptomology and "bothersomeness" of the symptoms; and 4) overall cost.

Conditions

  • Urinary Tract Infections-UTI

Interventions

OTHER

culture versus Molecular diagnostics

Treatment based on the results of the FH C \& S testing - Odd Numbers on randomization table

Sponsors & Collaborators

  • Southwest Regional PCR, LLC

    lead INDUSTRY

Principal Investigators

  • Michael McDonald, MD · Florida Hospital Celebration Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-15
Primary Completion
2016-12-31
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02623179 on ClinicalTrials.gov